3-(2,2,2-trimethylhydrazine)propionate and allicin

3-(2,2,2-trimethylhydrazine)propionate has been researched along with allicin in 1 studies

Compound Research Comparison

Studies (3-(2,2,2-trimethylhydrazine)propionate)	Trials (3-(2,2,2-trimethylhydrazine)propionate)	Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate)	Studies (allicin)	Trials (allicin)	Recent Studies (post-2010) (allicin)
251	35	105	601	29	339

Protein Interaction Comparison

Protein	Taxonomy	3-(2,2,2-trimethylhydrazine)propionate (IC50)	allicin (IC50)
Mitochondrial 2-oxodicarboxylate carrier	Homo sapiens (human)		0.011

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bode, LM; Eggers, M; Jahn, D; Jasper, J; Lubitz, W; Moser, J; Neubauer, K; Piskol, F; Reijerse, E; Slusarenko, A	1

Other Studies

1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and allicin

Article	Year
Two-component carnitine monooxygenase from Escherichia coli: functional characterization, inhibition and mutagenesis of the molecular interface. Bioscience reports, 2022, 09-30, Volume: 42, Issue:9 Topics: Cardiovascular Diseases; Carnitine; Disulfides; Escherichia coli; Flavin Mononucleotide; Humans; Methylamines; Methylhydrazines; Mixed Function Oxygenases; Mutagenesis; Oxidoreductases; Oxygenases; Sulfinic Acids	2022

Article

Year

Two-component carnitine monooxygenase from Escherichia coli: functional characterization, inhibition and mutagenesis of the molecular interface.

Bioscience reports, 2022, 09-30, Volume: 42, Issue:9

Topics: Cardiovascular Diseases; Carnitine; Disulfides; Escherichia coli; Flavin Mononucleotide; Humans; Methylamines; Methylhydrazines; Mixed Function Oxygenases; Mutagenesis; Oxidoreductases; Oxygenases; Sulfinic Acids

2022